Objective: To determine whether a controlled ovarian hyperstimulation (COH) regimen that
involves GnRH agonist (GnRH-a) discontinuation before administration of gonadotropins …

BACKGROUND Since the most recent Cochrane review on hMG versus rFSH for controlled
ovarian hyperstimulation following a long down-regulation protocol, several new trials have …

The current understanding of human growth hormone (hGH; here GH) action is that the
molecule is a 191-amino acid, single-chain polypeptide that is synthesized, stored and …

There is an ongoing debate over the optimal dose of urinary HCG (u-HCG) that can trigger
final oocyte maturation, leading to higher IVF success rate without increasing the risk of …

BACKGROUND Poor ovarian response is a common clinical problem, affecting up to 26% of
IVF cycles. For these women, addition of recombinant luteinizing hormone (rLH) to ovarian …

Background Individualization of the follicle-stimulating hormone (FSH) starting dose is
considered standard clinical practice during controlled ovarian stimulation (COS) in patients …

BACKGROUND Most reviews of IVF ovarian stimulation protocols have insufficiently
accounted for various patient populations, such as ovulatory women, women with polycystic …

Growth hormone (GH) is not approved for use during conception and pregnancy.
Nevertheless, data from the clinical care practice reveal that most women concieve on GH …

Objective We have investigated the beneficial effect of a somatotroph axis stimulation on
ovarian response to gonadotropin. Design Growth hormone-releasing hormone (GH-RH) …

The objectives of this study were to investigate the clinical efficacy of growth hormone (GH)
in patients experiencing repeat implantation failure (RIF) and explore the possible …